BFS
Bard Financial Services’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.17M | Buy |
134,745
+12,500
| +10% | +$480K | 0.62% | 50 |
|
|
2025
Q1 | $4.74M | Buy |
122,245
+43,150
| +55% | +$1.67M | 0.58% | 50 |
|
|
2024
Q4 | $2.67M | Buy |
79,095
+21,950
| +38% | +$742K | 0.32% | 72 |
|
|
2024
Q3 | $2.34M | Sell |
57,145
-8,000
| -12% | -$327K | 0.28% | 77 |
|
|
2024
Q2 | $2.51M | Sell |
65,145
-1,400
| -2% | -$53.9K | 0.26% | 78 |
|
|
2024
Q1 | $2.85M | Buy |
66,545
+25,500
| +62% | +$1.09M | 0.3% | 74 |
|
|
2023
Q4 | $1.52M | Buy |
41,045
+34,100
| +491% | +$1.26M | 0.17% | 99 |
|
|
2023
Q3 | $252K | Buy |
6,945
+700
| +11% | +$25.4K | 0.03% | 193 |
|
|
2023
Q2 | $223K | Hold |
6,245
| – | – | 0.02% | 288 |
|
|
2023
Q1 | $222K | Hold |
6,245
| – | – | 0.02% | 288 |
|
|
2022
Q4 | $219K | Buy |
+6,245
| New | +$219K | 0.02% | 272 |
|
|
2021
Q1 | – | Sell |
-10,245
| Closed | -$377K | – | 264 |
|
|
2020
Q4 | $377K | Buy |
+10,245
| New | +$377K | 0.04% | 190 |
|